The importance of CTLA‐4 polymorphism and human leukocyte antigen genotype for the induction of diabetes‐associated cytokine response in healthy school children
暂无分享,去创建一个
[1] J. Ilonen,et al. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. , 1995, BioTechniques.
[2] L. Kinnunen,et al. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. , 2002, Diabetes & metabolism.
[3] J. Ilonen,et al. The association of CTLA‐4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5‐year‐old children , 2006, Clinical and experimental immunology.
[4] J. Ludvigsson,et al. Peptide from glutamic acid decarboxylase similar to coxsackie B virus stimulates IFN-γ mRNA expression in Th1-like lymphocytes from children with recent-onset insulin-dependent diabetes mellitus , 1998, Acta Diabetologica.
[5] O. Vaarala,et al. Vaccinations May Induce Diabetes‐Related Autoantibodies in One‐Year‐Old Children , 2003, Annals of the New York Academy of Sciences.
[6] Irun R Cohen,et al. Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens , 1997, Diabetes.
[7] B. Prabhakar,et al. Targeted CTLA-4 Engagement Induces CD4+CD25+CTLA-4high T Regulatory Cells with Target (Allo)antigen Specificity1 , 2004, The Journal of Immunology.
[8] P. Ott,et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. , 2003, Journal of autoimmunity.
[9] J. Franklyn,et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. , 1999, The Journal of clinical endocrinology and metabolism.
[10] J. Todd,et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. , 1996, Human molecular genetics.
[11] I. Cohen,et al. Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination , 2002, Diabetologia.
[12] A. Field,et al. Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells. , 2003, Journal of autoimmunity.
[13] Kaizhai Shen,et al. CD4 , 1990 .
[14] M. Karlsson Faresjö,et al. Diminished Th1‐Like Response to Autoantigens in Children with a High Risk of Developing Type 1 Diabetes , 2005, Scandinavian journal of immunology.
[15] I. Cohen,et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Usadel,et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.
[17] J. Ludvigsson,et al. Th1-like dominance in high-risk first-degree relatives of Type I diabetic patients , 2000, Diabetologia.
[18] P. Nickerson,et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. , 1997, Journal of immunology.
[19] U. Grohmann,et al. CD40 Ligand and CTLA-4 Are Reciprocally Regulated in the Th1 Cell Proliferative Response Sustained by CD8+ Dendritic Cells1 , 2002, The Journal of Immunology.
[20] J. Ludvigsson,et al. Nicotinamide reduces high secretion of IFN-gamma in high-risk relatives even though it does not prevent type 1 diabetes. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[21] C. Benoist,et al. Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.
[22] M. Knip,et al. Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland , 1993, Diabetologia.
[23] R. Pirskanen,et al. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis , 2002, Genes and Immunity.
[24] U. Grohmann,et al. CTLA-4–Ig regulates tryptophan catabolism in vivo , 2002, Nature Immunology.
[25] E. Thorsby,et al. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus , 1993, Diabetologia.
[26] Å. Lernmark,et al. Development of Type 1 Diabetes in Wild Bank Voles Associated With Islet Autoantibodies and the Novel Ljungan Virus , 2003, International journal of experimental diabesity research.
[27] J. Ilonen,et al. Population‐based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA‐DQB1, HLA‐DQA1 and HLA‐DRB1 loci , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[28] O. Vaarala,et al. Induction of Diabetes‐Related Autoantibodies below Cutoff for “Positivity” in Young Nondiabetic Children , 2003, Annals of the New York Academy of Sciences.
[29] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[30] J. Ludvigsson,et al. Cytokine Profile in Children During the First 3 Months after the Diagnosis of Type 1 Diabetes , 2004, Scandinavian journal of immunology.
[31] J. Bluestone. Is CTLA-4 a master switch for peripheral T cell tolerance? , 1997, Journal of immunology.
[32] L. Nyström,et al. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0–34 years group in Sweden 1983 to 1998 , 2002, Diabetologia.
[33] J. Ilonen,et al. HLA class II associated risk and protection against multiple sclerosis—a Finnish family study , 2002, Journal of Neuroimmunology.
[34] J. Gribben,et al. CTLA4 mediates antigen-specific apoptosis of human T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Mandrup-Poulsen,et al. On the Pathogenesis of Insulin-Dependent Diabetes Mellitus — A Discussion of Three Recently Proposed Models , 1989 .
[36] J. Ilonen,et al. Diminished IFN‐γ response to diabetes‐associated autoantigens in children at diagnosis and during follow up of type 1 diabetes , 2006 .
[37] M. A. Bowman,et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. , 1994, The Journal of clinical investigation.
[38] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[39] J. Ilonen,et al. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes. , 2006, Diabetes/metabolism research and reviews.
[40] J. Rotter,et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. , 1997, Human molecular genetics.
[41] Luc J. Smink,et al. Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support Ctla4 and Nramp1 as Candidates for Idd5.1 and Idd5.2 in the Nonobese Diabetic Mouse 1 , 2004, The Journal of Immunology.
[42] C. Ray,et al. COXSACKIE B VIRUS ANTIBODY RESPONSES IN JUVENILE‐ONSET DIABETES MELLITUS , 1980, Clinical endocrinology.
[43] G. Eisenbarth. Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .
[44] J. She. Susceptibility to type I diabetes: HLA-DQ and DR revisited. , 1996, Immunology today.
[45] M. Menser,et al. RUBELLA INFECTION AND DIABETES MELLITUS , 1978, The Lancet.
[46] D. Devine,et al. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy , 1995, European journal of immunology.